{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:45:08Z","timestamp":1782783908686,"version":"3.54.5"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004946","name":"National Chung Hsing University","doi-asserted-by":"publisher","award":["113-2113-M-005-016-MY3"],"award-info":[{"award-number":["113-2113-M-005-016-MY3"]}],"id":[{"id":"10.13039\/501100004946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004946","name":"National Chung Hsing University","doi-asserted-by":"publisher","award":["113-2311-B-005-006-MY3"],"award-info":[{"award-number":["113-2311-B-005-006-MY3"]}],"id":[{"id":"10.13039\/501100004946","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ijbiomac.2024.136996","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T20:55:30Z","timestamp":1730408130000},"page":"136996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"P4","title":["Antiviral drug development by targeting RNA binding site, oligomerization and nuclear export of influenza nucleoprotein"],"prefix":"10.1016","volume":"282","author":[{"given":"Sankar","family":"Panthi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhen-Yi","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan","family":"Satange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Ching","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hon","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.136996_bb0005","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.chom.2010.05.009","article-title":"Influenza virus evolution, host adaptation, and pandemic formation","volume":"7","author":"Taubenberger","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-3-642-20718-1_2","article-title":"Viruses: definition, structure, classification","author":"Modrow","year":"2013","journal-title":"Mol. Virol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0015","series-title":"Molecular Virology of Human Pathogenic Viruses","author":"Ryu","year":"2016"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.rie.2022.08.001","article-title":"Socio-economic and environmental factors in the global spread of COVID-19 outbreak","volume":"76","author":"Zoungrana","year":"2022","journal-title":"Res. Econ."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0025","first-page":"7","article-title":"Infectious disease and economics: the case for considering multi-sectoral impacts","author":"Smith","year":"2019","journal-title":"One Health"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0002-y","article-title":"Influenza","volume":"4","author":"Krammer","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tim.2014.01.010","article-title":"Bat-derived influenza-like viruses H17N10 and H18N11","volume":"22","author":"Wu","year":"2014","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0040","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1146\/annurev.pathmechdis.3.121806.154316","article-title":"The pathology of influenza virus infections","volume":"3","author":"Taubenberger","year":"2008","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0045","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1016\/j.cell.2023.08.011","article-title":"Airborne transmission of human-isolated avian H3N8 influenza virus between ferrets","volume":"186","author":"Sun","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/546207a","article-title":"Influenza: a viral world war","volume":"546","author":"Tansey","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0055","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijbiomac.2021.01.076","article-title":"Trends and strategies to combat viral infections: a review on FDA approved antiviral drugs","volume":"172","author":"Tompa","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0060","doi-asserted-by":"crossref","first-page":"913","DOI":"10.15585\/mmwr.mm7129a1","article-title":"Influenza activity and composition of the 2022\u201323 influenza vaccine-United States, 2021\u201322 season","volume":"71","author":"Merced-Morales","year":"2022","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0065","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41573-023-00692-8","article-title":"Accelerating antiviral drug discovery: lessons from COVID-19","volume":"22","author":"von Delft","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0070","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir Marboxil for uncomplicated Influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0075","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10096-020-03840-9","article-title":"Influenza and antiviral resistance: an overview","volume":"39","author":"Lampejo","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41564-019-0639-7","article-title":"Emerging antiviral resistance","volume":"5","author":"Kormuth","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0085","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1586\/14760584.2013.824709","article-title":"The evolving history of influenza viruses and influenza vaccines","volume":"12","author":"Hannoun","year":"2013","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0090","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.tim.2022.09.015","article-title":"A structural understanding of influenza virus genome replication","volume":"31","author":"Zhu","year":"2023","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0095","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.tim.2018.05.013","article-title":"Influenza virus","volume":"26","author":"Hutchinson","year":"2018","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0100","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/jvi.10.4.795-800.1972","article-title":"Structure of the ribonucleoprotein of influenza virus","volume":"10","author":"Compans","year":"1972","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0105","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41564-020-0675-3","article-title":"Structural insights into influenza A virus ribonucleoproteins reveal a processive helical track as transcription mechanism","volume":"5","author":"Coloma","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0110","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1126\/science.1227270","article-title":"Organization of the influenza virus replication machinery","volume":"338","author":"Moeller","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0115","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.cmi.2016.07.007","article-title":"Functional balance between neuraminidase and haemagglutinin in influenza viruses","volume":"22","author":"Gaymard","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0120","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1016\/j.vaccine.2012.04.085","article-title":"Nuclear import of the influenza a virus transcriptional machinery","volume":"30","author":"Hutchinson","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0125","doi-asserted-by":"crossref","first-page":"16557","DOI":"10.1073\/pnas.2002828117","article-title":"Dissecting the mechanism of signaling-triggered nuclear export of newly synthesized influenza virus ribonucleoprotein complexes","volume":"117","author":"Schreiber","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-18108-1","article-title":"Selective flexible packaging pathways of the segmented genome of influenza A virus","volume":"11","author":"Haralampiev","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.virusres.2009.05.010","article-title":"Influenza virus morphogenesis and budding","volume":"143","author":"Nayak","year":"2009","journal-title":"Virus Res."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0140","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.virol.2014.01.023","article-title":"Large-scale analysis of influenza A virus nucleoprotein sequence conservation reveals potential drug-target sites","volume":"454\u2013455","author":"Kukol","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0145","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1128\/JVI.02642-08","article-title":"Mutational analysis of conserved amino acids in the influenza A virus nucleoprotein","volume":"83","author":"Li","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0150","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1073\/pnas.0307127101","article-title":"3D structure of the influenza virus polymerase complex: localization of subunit domains","volume":"101","author":"Area","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0155","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nbt.1638","article-title":"Identification of influenza A nucleoprotein as an antiviral target","volume":"28","author":"Kao","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0160","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/nature05379","article-title":"The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA","volume":"444","author":"Ye","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0165","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11427-009-0064-x","article-title":"Structure and sequence analysis of influenza A virus nucleoprotein","volume":"52","author":"Ng","year":"2009","journal-title":"Sci. China C Life S.ci"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0239899","article-title":"Interaction between influenza A virus nucleoprotein and PB2 cap-binding domain is mediated by RNA","volume":"15","author":"Szeto","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1128\/JVI.02293-07","article-title":"Interaction of the influenza A virus nucleocapsid protein with the viral RNA polymerase potentiates unprimed viral RNA replication","volume":"83","author":"Newcomb","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0180","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.2217\/fmb.13.81","article-title":"Avian influenza: virology, diagnosis and surveillance","volume":"8","author":"El Zowalaty","year":"2013","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0185","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1021\/acsinfecdis.7b00120","article-title":"Broad spectrum inhibitor of influenza A and B viruses targeting the viral nucleoprotein","volume":"4","author":"White","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0190","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1128\/JVI.01434-06","article-title":"Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication","volume":"81","author":"Ozawa","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0195","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.tips.2009.03.002","article-title":"Emerging antiviral targets for influenza A virus","volume":"30","author":"Krug","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0200","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1128\/JVI.02332-14","article-title":"Regulation of influenza A virus nucleoprotein oligomerization by phosphorylation","volume":"89","author":"Turrell","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1004826","article-title":"Phosphorylation at the homotypic interface regulates nucleoprotein oligomerization and assembly of the influenza virus replication machinery","volume":"11","author":"Mondal","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0210","first-page":"8","article-title":"Mapping the phosphoproteome of influenza A and B viruses by mass spectrometry","author":"Hutchinson","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0215","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.virol.2018.05.002","article-title":"Phosphorylation and dephosphorylation of threonine 188 in nucleoprotein is crucial for the replication of influenza A virus","volume":"520","author":"Li","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0220","first-page":"10","article-title":"Phosphorylation status of tyrosine 78 residue regulates the nuclear export and ubiquitination of influenza A virus nucleoprotein","author":"Cui","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0225","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/archinte.160.10.1485","article-title":"Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients","volume":"160","author":"Keyser","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0230","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2174\/187152607783018745","article-title":"Influenza viruses: basic biology and potential drug targets","volume":"7","author":"Basler","year":"2007","journal-title":"Infect. Disord. Drug Targets"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0235","series-title":"Seasonal Influenza Vaccination: Developing and Strengthening National Programmes","first-page":"1","author":"WHO","year":"2023"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0240","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/irv.12446","article-title":"Influenza antivirals currently in late-phase clinical trial","volume":"11","author":"Koszalka","year":"2017","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0245","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/QCO.0000000000000532","article-title":"Influenza virus polymerase inhibitors in clinical development","volume":"32","author":"Hayden","year":"2019","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0250","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coviro.2019.01.006","article-title":"Baloxavir marboxil: the new influenza drug on the market","volume":"35","author":"O\u2019Hanlon","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0255","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.tibtech.2019.09.009","article-title":"Next-generation sequencing: an eye-opener for the surveillance of antiviral resistance in influenza","volume":"38","author":"Van Poelvoorde","year":"2020","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0260","first-page":"95","article-title":"Inhibition of influenza A virus replication by a marine derived quinolone alkaloid targeting virus nucleoprotein","author":"Zhang","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0265","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.virs.2023.09.003","article-title":"Allopregnanolone targets nucleoprotein as a novel influenza virus inhibitor","volume":"38","author":"Dong","year":"2023","journal-title":"Virol. Sin."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0270","first-page":"15","article-title":"Retracted and republished from: \u201cthe current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs.\u201d","author":"Li","year":"2024","journal-title":"MBio"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0275","series-title":"Reference Module in Biomedical Sciences","author":"Rimantadine","year":"2016"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00119-20","article-title":"Population pharmacokinetics and exposure-response relationships of baloxavir marboxil in influenza patients at high risk of complications","volume":"64","author":"Koshimichi","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0285","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S1473-3099(20)30004-9","article-title":"Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Ison","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0290","first-page":"346","article-title":"Treatment-emergent influenza variant viruses with reduced baloxavir susceptibility: impact on clinical and virologic outcomes in uncomplicated influenza","volume":"221","author":"Uehara","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0295","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1473-3099(21)00469-2","article-title":"Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial","volume":"22","author":"Kumar","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0300","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s40265-018-0899-1","article-title":"Baloxavir: first global approval","volume":"78","author":"Heo","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-27890-4","article-title":"Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil","volume":"8","author":"Omoto","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0310","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0315","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/INF.0b013e31829be4bc","article-title":"Oseltamivir treatment for influenza in hospitalized children without underlying diseases","volume":"32","author":"Bueno","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"9218","key":"10.1016\/j.ijbiomac.2024.136996_bb0320","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(00)02288-1","article-title":"Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group","volume":"355","author":"Nicholson","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0325","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(14)62449-1","article-title":"Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials","volume":"385","author":"Dobson","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0330","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/cid\/cix1040","article-title":"Efficacy and safety of oseltamivir in children: systematic review and individual patient data meta-analysis of randomized controlled trials","volume":"66","author":"Malosh","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0335","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1503\/cmaj.100313","article-title":"Oseltamivir-resistant pandemic H1N1 influenza","volume":"183","author":"Webster","year":"2011","journal-title":"CMAJ Can. Med. Assoc. J."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0340","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/infdis\/jis765","article-title":"Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2\u00a0years with influenza","volume":"207","author":"Kimberlin","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.136996_bb0345","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/ja963036t","article-title":"Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity","volume":"119","author":"Kim","year":"1997","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0350","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/QCO.0000000000000498","article-title":"Neuraminidase inhibitor resistance in influenza: a clinical perspective","volume":"31","author":"Lee","year":"2018","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0355","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1517\/14740330902840519","article-title":"Oseltamivir for treatment and prophylaxis of influenza infection","volume":"8","author":"Schirmer","year":"2009","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0360","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.2147\/DDDT.S46654","article-title":"Safety and efficacy of peramivir for influenza treatment","volume":"8","author":"Hata","year":"2014","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0365","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/irv.12794","article-title":"Intravenous peramivir vs oral oseltamivir in high-risk emergency department patients with influenza: results from a pilot randomized controlled study","volume":"15","author":"Hsieh","year":"2021","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0370","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s40265-018-0981-8","article-title":"Peramivir: a review in uncomplicated influenza","volume":"78","author":"Scott","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0375","first-page":"497","article-title":"Outcomes and adverse effects with peramivir for the treatment of influenza h1n1 in critically ill pediatric patients","volume":"24","author":"Witcher","year":"2019","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0380","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2005.10.002","article-title":"Anti-influenza virus activity of peramivir in mice with single intramuscular injection","volume":"69","author":"Bantia","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0385","first-page":"1","article-title":"Assessment of adverse events related to anti-influenza neuraminidase inhibitors using the FDA adverse event reporting system and online patient reviews","volume":"10","author":"Han","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0390","first-page":"140","article-title":"Intravenous zanamivir in hospitalized patients with influenza","author":"Bradley","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0395","doi-asserted-by":"crossref","first-page":"780","DOI":"10.4103\/0253-7613.103301","article-title":"Comparison of efficacy and safety of oseltamivir and zanamivir in pandemic influenza treatment","volume":"44","author":"Tuna","year":"2012","journal-title":"Indian J. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.g2547","article-title":"Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments","volume":"348","author":"Heneghan","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0405","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1021\/jm0002679","article-title":"BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design","volume":"43","author":"Babu","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0410","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/363418a0","article-title":"Rational design of potent sialidase-based inhibitors of influenza virus replication","volume":"363","author":"Itzstein","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11121747","article-title":"Nucleoprotein as a promising antigen for broadly protective influenza vaccines","author":"Rak","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0420","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2174\/1568026617666170224122508","article-title":"Influenza A virus nucleoprotein: a highly conserved multi-functional viral protein as a hot antiviral drug target","volume":"17","author":"Hu","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0425","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/jcmm.13467","article-title":"Identification of a novel compound targeting the nuclear export of influenza A virus nucleoprotein","volume":"22","author":"Huang","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0430","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1128\/JVI.02642-08","article-title":"Mutational analysis of conserved amino acids in the Influenza a virus nucleoprotein","volume":"83","author":"Li","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0435","first-page":"95","article-title":"Discovery of a novel specific inhibitor targeting Influenza a virus nucleoprotein with pleiotropic inhibitory effects on various steps of the viral life cycle","author":"Yang","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v12030337","article-title":"A quinolinone compound inhibiting the oligomerization of nucleoprotein of influenza A virus prevents the selection of escape mutants","volume":"12","author":"Makau","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0445","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1128\/AAC.02335-12","article-title":"Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza a virus","volume":"57","author":"Lejal","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0450","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.febslet.2012.11.016","article-title":"Oligomerization of the carboxyl terminal domain of the human coronavirus 229E nucleocapsid protein","volume":"587","author":"Lo","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0455","doi-asserted-by":"crossref","first-page":"19151","DOI":"10.1073\/pnas.1013592107","article-title":"High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity","volume":"107","author":"Su","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0460","doi-asserted-by":"crossref","first-page":"RRN1253","DOI":"10.1371\/currents.RRN1253","article-title":"Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo","volume":"3","author":"Fedichev","year":"2011","journal-title":"PLoS Curr."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0465","first-page":"1","article-title":"Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0470","first-page":"6","article-title":"Structural characterization of H1N1 nucleoprotein-nucleozin binding sites","author":"Pang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0475","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1021\/jm2013503","article-title":"Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein","volume":"55","author":"Cheng","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0480","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1039\/C9RA10828A","article-title":"Design, synthesis and in vitro biological evaluation of isoxazol-4-carboxa piperidyl derivatives as new anti-influenza A agents targeting virus nucleoprotein","volume":"10","author":"Pei","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0485","doi-asserted-by":"crossref","first-page":"15366","DOI":"10.1073\/pnas.1107906108","article-title":"Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers","volume":"108","author":"Gerritz","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0490","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1021\/acsinfecdis.7b00120","article-title":"Broad spectrum inhibitor of influenza A and B viruses targeting the viral nucleoprotein","volume":"4","author":"White","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0495","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.antiviral.2016.07.024","article-title":"Antiviral activity of KR-23502 targeting nuclear export of influenza B virus ribonucleoproteins","volume":"134","author":"Jang","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0500","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/jcmm.13467","article-title":"Identification of a novel compound targeting the nuclear export of influenza A virus nucleoprotein","volume":"22","author":"Huang","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0505","first-page":"129","article-title":"Exploring the anti-influenza virus activity of novel triptolide derivatives targeting nucleoproteins","author":"Jiang","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0510","first-page":"95","article-title":"Discovery of ligustrazine and chalcone derivatives as novel viral nucleoprotein nuclear export inhibitors against influenza viruses","author":"Li","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0515","first-page":"9","article-title":"p-Cymene impairs SARS-CoV-2 and Influenza a (H1N1) viral replication: in silico predicted interaction with SARS-CoV-2 nucleocapsid protein and H1N1 nucleoprotein","author":"Panagiotopoulos","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0520","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejmech.2015.08.016","article-title":"Synthesis and inhibitory effects of novel pyrimido-pyrrolo-quinoxalinedione analogues targeting nucleoproteins of influenza A virus H1N1","volume":"102","author":"Lin","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0525","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1021\/acs.jmedchem.8b01683","article-title":"Design, synthesis, and biological evaluation of itaconic acid derivatives as potential anti-influenza agents","volume":"62","author":"Sethy","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0530","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1080\/07391102.2014.979230","article-title":"Structure-based design of novel naproxen derivatives targeting monomeric nucleoprotein of influenza A virus","volume":"33","author":"Tarus","year":"2015","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0535","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.celrep.2019.04.053","article-title":"Naproxen exhibits broad anti-influenza virus activity in mice by impeding viral nucleoprotein nuclear export","volume":"27","author":"Zheng","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0540","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbrc.2010.03.058","article-title":"Discovery of novel antiviral agents directed against the influenza a virus nucleoprotein using photo-cross-linked chemical arrays","volume":"394","author":"Hagiwara","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0545","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1021\/acs.jafc.7b00276","article-title":"Anti-influenza A virus activity of dendrobine and its mechanism of action","volume":"65","author":"Li","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1005062","article-title":"A novel antiviral target structure involved in the RNA binding, dimerization, and nuclear export functions of the influenza A virus nucleoprotein","volume":"11","author":"Kakisaka","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0555","doi-asserted-by":"crossref","DOI":"10.1186\/s12906-016-1469-2","article-title":"Designing and screening of universal drug from neem (Azadirachta indica) and standard drug chemicals against influenza virus nucleoprotein","volume":"16","author":"Ahmad","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0560","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1021\/jm500089r","article-title":"Structural basis for the identification of the N-terminal domain of coronavirus nucleocapsid protein as an antiviral target","volume":"57","author":"Lin","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0565","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.celrep.2019.04.053","article-title":"Naproxen exhibits broad anti-influenza virus activity in mice by impeding viral nucleoprotein nuclear export","volume":"27","author":"Zheng","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0570","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1021\/acs.jmedchem.8b00557","article-title":"From naproxen repurposing to naproxen analogues and their antiviral activity against influenza A virus","volume":"61","author":"Dilly","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0575","unstructured":"Kariko K, Weissman D. Us008748089B2: Rna Containing Modified Nucleosdes and Methods of Use Thereof 2014;2. https:\/\/pubchem.ncbi.nlm.nih.gov\/patent\/US-2013197068-A1."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0580","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.antiviral.2013.07.018","article-title":"New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions","volume":"100","author":"Beyleveld","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0585","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3851\/IMP2235","article-title":"Influenza nucleoprotein: promising target for antiviral chemotherapy","volume":"23","author":"Cianci","year":"2013","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0590","first-page":"363","article-title":"A small-molecule fusion inhibitor of influenza virus is orally active in mice","author":"Van Dongen","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0595","first-page":"93","article-title":"In vitro and in vivo efficacy of Ingavirin against strains of pandemic influenza virus A(H1N1\/09)","author":"Shishkina","year":"2011","journal-title":"Zh. Mikrobiol. Epidemiol. Immunobiol."},{"issue":"19\u201327","key":"10.1016\/j.ijbiomac.2024.136996_bb0600","first-page":"20608077","article-title":"Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models","volume":"55","author":"Leneva","year":"2010","journal-title":"Vopr. Virusol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0605","first-page":"8","article-title":"Antiviral activity of Ingavirin in experimental lethal influenza due to influenza virus B in albino mice","volume":"55","author":"Zarubaev","year":"2010","journal-title":"Antibiot. Khimioter."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0610","first-page":"14","article-title":"The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs","author":"Li","year":"2023","journal-title":"MBio"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0615","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s15010-013-0546-4","article-title":"Development of universal influenza vaccines based on influenza virus M and NP genes","volume":"42","author":"Zheng","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0620","article-title":"Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L","volume":"39","author":"Ft Townsend","year":"1984","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0625","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1099\/0022-1317-66-6-1327","article-title":"Induction of Influenza a virus cross-reactive cytotoxic T cells by a nucleoprotein\/haemagglutinin preparation","author":"Wraith","year":"1985","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0630","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1099\/0022-1317-68-2-433","article-title":"Purified Influenza virus nucleoprotein protects mice from lethal infection","volume":"68","author":"Wraith","year":"1987","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0635","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1002\/jmv.27662","article-title":"Evolutionary conservation and positive selection of influenza a nucleoprotein CTL epitopes for universal vaccination","volume":"94","author":"McGee","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0640","first-page":"11","article-title":"CpG 1018 is an effective adjuvant for influenza nucleoprotein","author":"Li","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0645","first-page":"277","article-title":"Revisiting the dimensions of universal vaccine with special focus on COVID-19: efficacy versus methods of designing","author":"Jaishwal","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0650","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ijbiomac.2022.12.066","article-title":"Designing multi-epitope mRNA construct as a universal influenza vaccine candidate for future epidemic\/pandemic preparedness","volume":"226","author":"Rcheulishvili","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0655","first-page":"254","article-title":"In silico design of a broad-spectrum multiepitope vaccine against influenza virus","author":"Yuan","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0660","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.2105\/AJPH.87.12.1944","article-title":"The impact of influenza epidemics on mortality: introducing a severity index","volume":"87","author":"Simonsen","year":"1997","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-023-04764-1","article-title":"In vivo secondary structural analysis of influenza A virus genomic RNA","volume":"80","author":"Mirska","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0670","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nbt.1638","article-title":"Identification of influenza A nucleoprotein as an antiviral target","volume":"28","author":"Kao","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0675","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1021\/ac2022426","article-title":"Development of an anti-influenza drug screening assay targeting nucleoproteins with tryptophan fluorescence quenching","volume":"84","author":"Hung","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0680","doi-asserted-by":"crossref","first-page":"16515","DOI":"10.1073\/pnas.1113107108","article-title":"E339\u2026R416 salt bridge of nucleoprotein as a feasible target for influenza virus inhibitors","volume":"108","author":"Shen","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v12030337","article-title":"A quinolinone compound inhibiting the oligomerization of nucleoprotein of influenza A virus prevents the selection of escape mutants","volume":"12","author":"Makau","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0690","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.antiviral.2012.09.013","article-title":"Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection","volume":"96","author":"Lee","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0695","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.2174\/09298673113209990208","article-title":"Viral RNA polymerase: a promising antiviral target for influenza A virus","volume":"20","author":"Shi","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0700","first-page":"12","article-title":"Development of NP-based universal vaccine for influenza A viruses","author":"Sayedahmed","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0705","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/infdis\/jiab532","article-title":"Phase 1 randomized, placebo-controlled, dose-escalating study to evaluate OVX836, a nucleoprotein-based influenza vaccine: intramuscular results","volume":"226","author":"Withanage","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0710","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0715","first-page":"155","article-title":"Computational drug repurposing by exploiting large-scale gene expression data: strategy, methods and applications","author":"He","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112275","article-title":"A medicinal chemistry perspective of drug repositioning: recent advances and challenges in drug discovery","volume":"195","author":"Pillaiyar","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0725","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2036.1997.115286000.x","article-title":"NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects","volume":"11","author":"Davies","year":"1997","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0730","doi-asserted-by":"crossref","first-page":"11178","DOI":"10.1073\/pnas.1204524109","article-title":"Identifying mechanism-of-action targets for drugs and probes","volume":"109","author":"Gregori-Puigjan\u00e9","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0735","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.chembiol.2014.09.001","article-title":"Small-molecule inhibitors of protein-protein interactions: progressing toward the reality","volume":"21","author":"Arkin","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0740","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrd1343","article-title":"Small-molecule inhibitors of protein-protein interactions: progressing towards the dream","volume":"3","author":"Arkin","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0745","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.bpj.2024.01.013","article-title":"Targeting protein-protein interaction interfaces with antiviral N protein inhibitor in SARS-CoV-2","volume":"123","author":"Hong","year":"2024","journal-title":"Biophys. J."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0750","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1021\/acs.jmedchem.9b01913","article-title":"Structure-based stabilization of non-native protein-protein interactions of coronavirus nucleocapsid proteins in antiviral drug design","volume":"63","author":"Lin","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0755","first-page":"1","article-title":"Targeting the N-terminus domain of the coronavirus nucleocapsid protein induces abnormal oligomerization via allosteric modulation","volume":"9","author":"Hsu","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0760","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2013.12.009","article-title":"The SARS coronavirus nucleocapsid protein \u2014 forms and functions","volume":"103","author":"Chang","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0765","first-page":"20","article-title":"The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics","author":"Wu","year":"2023","journal-title":"Virol. J."},{"key":"10.1016\/j.ijbiomac.2024.136996_bb0770","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.apsb.2021.11.018","article-title":"Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins","volume":"12","author":"Hou","year":"2022","journal-title":"Acta Pharm. Sin. B"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302407805X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302407805X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:12:48Z","timestamp":1782781968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302407805X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":154,"alternative-id":["S014181302407805X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136996","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral drug development by targeting RNA binding site, oligomerization and nuclear export of influenza nucleoprotein","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"136996"}}